"Assessing Safety and Clinical Outcomes of Rinvecalinase Alfa (DM199) in Acute Ischemic Stroke Patients Pre-treated with Intravenous Thrombolytics Only" The poster is P-704. On Thursday May 22 ...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today a poster presentation of ...

today announced that the Company will present a Late-Breaking scientific poster at the upcoming 2025 American Thoracic Society (ATS) International Conference taking place May 16-21, 2025 ...

today announced the presentation of a poster at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025 in Chicago. The presentation describes the company’s ...

Abstract and poster presentation details are below: Title: "Phase 1 dose escalation results of the WEE1 inhibitor, azenosertib, in combination with encorafenib and cetuximab in patients with ...

In addition, a trial-in-progress poster on ... be presented at the conference. Full abstracts will be available on the ASCO website on May 22, 2025, at 5:00 pm ET. Oral Presentation Title: Phase ...

Adagene Inc. announced a poster presentation for the ASCO 2025 conference in Chicago, highlighting the safety and efficacy of its product, ADG126, an anti-CTLA-4 masking antibody, in combination ...

How can you use royalty-free images and video clips? From social media ads to billboards, PowerPoint presentations to feature films, you're free to modify, resize and customize every asset on iStock — ...

KAT2A/B is a histone acetyltransferase that is associated with multiple tumor types. Details for Auron's poster presentation are below and can be found via the AACR online itinerary planner: Abstract ...

With an 86-77 victory over Tennessee on Sunday, the Gators captured the Southeastern Conference’s men’s ... championship with two commemorative posters from The Gainesville Sun.

Shares of energy drink maker Celsius Holdings (CELH) jumped on Wednesday morning, ahead of the company's latest earnings report and a presentation from executives at a conference. While there is ...

Sonnet BioTherapeutics Holdings, Inc. announced that its abstract has been accepted for a poster presentation at the 2025 American Association for Cancer Research (AACR) IO Conference, scheduled ...